Verastem, Inc.VSTMNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+12.8%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
+12.8%/yr
Annual compound
Percentile
P79
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202540.90%
202432.56%
202321.36%
202228.49%
2021-4.90%
2020-9.62%
20194.88%
2018-5.98%
2017134.71%
2016-51.24%